Clik here to view.
Spectrum Pharmaceuticals Highlights Poziotinib Data in Non-Small-Cell Lung...
HENDERSON, Nev. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and...
View ArticleClik here to view.
Interim Analysis of Ignyta’s Entrectinib Suggests Potential Best-in-Class...
SAN DIEGO Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, today announced updated results from its clinical trials, including the STARTRK-2 trial, of...
View ArticleClik here to view.
武田薬品がALK陽性非小細胞肺がんでのALUNBRIGTM（ブリガチニブ）のピボタル第2相ALTA試験の最新データを発表
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE: 4502）は本日、クリゾチニブ投与中に進行した局所進行性／転移性未分化リンパ腫キナーゼ（ALK）陽性非小細胞肺がん（NSCLC）患者でALUNBRIGTM（ブリガチニブ）を評価するピボタル第2相ALTA（ALK in Lung Cancer Trial of...
View ArticleClik here to view.
Second Sight Announces Appointments of Frank Vandeputte as Vice President and...
SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that provide useful...
View ArticleClik here to view.
Median Technologies Appoints Vivian Wang as General Manager, China and...
SOPHIA ANTIPOLIS, France Regulatory News: Median Technologies (Paris:ALMDT), The Imaging Phenomics Company® today announces the appointment of Vivian Wang as General Manager, China and the...
View ArticleClik here to view.
Clinigen Acquires Japan’s Largest Supplier of Unlicensed Medicines
BURTON-ON-TRENT, England Clinigen Group plc (AIM: CLIN, ‘Clinigen’ or the ‘Group’), the global pharmaceutical and services company, has today acquired International Medical Management Corporation...
View ArticleClik here to view.
ホールスターの新しい光安定剤AvoBrite®が、規制に関する課題を解決しつつ、卓越した光防御機能を提供
シカゴ （ビジネスワイヤ） — ホールスターは最近、光防御技術に関する20年に及ぶ経験を基に、当社の最新の革新成果となるAvoBrite®を発表しました。中国の規制に準拠したこの光安定剤は、韓国メーカーのコスマックスが提供するピプルーブ（VProve）ブランドの「デイリー・パーフェクト・サン・エッセンス」に調合されており、当社が開発に集中的に取り組んだ成果です。...
View ArticleClik here to view.
Hallstar的新款光稳定剂AvoBrite®在交付卓越防晒产品的同时解决客户面临的监管挑战
芝加哥 (美国商业资讯) — 在二十载的防晒技术基础上，Hallstar新近上市其最新创新产品AvoBrite®。该款光稳定剂符合中国标准，其首发是被韩国制造商Cosmax用于VProve的“日间完美防晒精华液”配方，是一次深度开发努力的最终成果。 美容及个人护理市场开发经理Dennis...
View ArticleClik here to view.
ADCセラピューティクスが登録試験リードプログラム2件の資金2億ドルを私募調達したと発表
スイス・ローザンヌ （ビジネスワイヤ） — 主要ながんを標的にした専有的な抗体薬物複合体（ADC）の開発を専門とするオンコロジー創薬／開発企業のADCセラピューティクス（ADCT）は本日、2億ドルを私募調達したと発表しました。今回の資金調達は応募超過となり、Auven...
View ArticleClik here to view.
ABEC 4,000 Liter Single-Use Bioreactor to Expand Emergent BioSolutions...
BETHLEHEM, Pa. ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced that Emergent BioSolutions will equip their Baltimore, Maryland bulk...
View ArticleClik here to view.
New Data Demonstrate VTI’s Multifocal Contact Lenses Effective in Reducing...
ATLANTA, Ga. Visioneering Technologies, Inc. (ASX:VTI) today announced the positive results of a new retrospective case series analysis on the impact of its NaturalVue® Multifocal 1 Day Contact...
View ArticleClik here to view.
ABEC 4,000升单次使用生物反应器扩大了Emergent BioSolutions的制造产能
宾夕法尼亚州伯利恒 (美国商业资讯) — 全球领先的生物制药制造一体化解决方案及服务提供商ABEC今天宣布，Emergent BioSolutions设在马里兰州巴尔的摩的大宗制造厂区（Bayview）将装备一台ABEC...
View ArticleClik here to view.
Breakthrough Medical and Pharmaceutical Funding Awarded to Consortium That...
MELBOURNE, Australia Regenerative skin company Avita Medical is delighted to be part of Accelerating Australia, a consortium that will inject up to $2 million into a breakthrough innovation project...
View ArticleClik here to view.
Kyowa Hakko Kirin Announces Marketing Authorisation Application for...
TOKYO Kyowa Hakko Kirin Co., Ltd. (TOKYO:4151) (President and CEO: Nobuo Hanai, “Kyowa Hakko Kirin”) today announces that its marketing authorisation application (MAA) for mogamulizumab, for the...
View ArticleClik here to view.
Hoya Reports Second Quarter Results; Record Half Year Results
TOKYO Hoya Corporation (TOKYO: 7741) today announced financial results for the second quarter ended September 30, 2017. During the quarter, revenue of the HOYA Group increased 18.2% year on year,...
View ArticleClik here to view.
Chi-Med Announces the Full Exercise of Underwriters’ Over-allotment Option
LONDON NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION...
View ArticleClik here to view.
Otsuka to Host Web Briefing on Tolvaptan Phase 3 Trial Results in Polycystic...
TOKYO & PRINCETON, N.J. Otsuka Pharmaceutical Co., Ltd. (OPCJ) and its affiliate Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) are pleased to invite investors and media...
View ArticleClik here to view.
Zebra Medical Vision要让人人都能容易地取得更加经济实惠的人工智能医疗照护
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 纽约 深度学习影像分析的领导企业Zebra Medical...
View ArticleClik here to view.
Astellas Reports First Half FY2017 Financial Results, Revises Fiscal Year...
TOKYO Astellas Pharma Inc. (TOKYO:4503) (President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced the financial results for the first six months of fiscal year 2017, ending March 31, 2018...
View ArticleClik here to view.
OMRON Increases Net Earnings 91.2% to JPY30.3 Billion on Solid Gains in Core...
KYOTO, Japan OMRON Corporation (TOKYO:6645) (Headquarters: Shimogyo-Ku, Kyoto. President and CEO: Yoshihito Yamada) today announced its consolidated operating results for the first half of fiscal...
View Article